Partial Epilepsies Clinical Trial
Official title:
An Open-Label, Multicenter, Multinational Study of Lacosamide as First Add-On Anti-epileptic Drug (AED) Treatment in Subjects With Partial-Onset Seizures
To evaluate the efficacy and safety of oral Lacosamide as first add on treatment in subjects with uncontrolled partial-onset seizures after prior treatment with a monotherapy Antiepileptic Drug (AED) regimen compared to subjects who have received treatment with at least 2 AEDs.
The study consisted of 3 Periods: Period 1: a 1-week Screening Phase, Period 2: a 30-week Treatment Phase (consisting of a 6-week Titration Phase and a 24-week Maintenance Phase), and Period 3: a 3-week Taper/Safety Follow-Up Phase. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00522275 -
Determine Safety and Efficacy of Long-term Oral Lacosamide in Patients With Partial Seizures
|
Phase 3 | |
| Completed |
NCT01235403 -
Trial to Assess Optimized Dosage of Lacosamide as add-on Therapy in Patients With Partial Onset Seizure
|
Phase 4 | |
| Completed |
NCT00552305 -
To Determine Tolerability and Efficacy of Long-term Oral Lacosamide in Patients With Partial Seizures
|
Phase 2 | |
| Completed |
NCT00655486 -
Study to Assess the Long-term Safety of Oral Lacosamide in Subjects With Partial-onset Seizures
|
Phase 3 | |
| Completed |
NCT00655551 -
Safety of Intravenous Lacosamide Dose Followed by Twice Daily Oral Lacosamide in Subjects With Partial-onset Seizures
|
Phase 3 |